BridgeMD
New treatment option for Cerebral Palsy
Official title Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy
ClinicalTrials.gov ID: NCT06428032
What this study is testing
- What it's testing
- This randomized controlled trial will compare the effects of neuroplastic and functional changes of Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) when presented in two periods (2HG; n=24) versus a single period (1HG; n=24) in people with bilateral CP. The 1HG will receive 65 hours of HABIT-ILE over one intervention period; the 2HG will receive 130 hours over two intervention periods, within 6 months apart.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 18
You may be able to join if
- Children with medical diagnosis of bilateral cerebral palsy
- Cognitive capacity and language that allows understanding and following the therapist's instructions.
- Manual Ability Classification System (MACS) levels I to III
- Bimanual Fine Motor Function (BFMF) levels I to III
- Gross Motor Function Classification System (GMFCS) levels I to III
You likely can't join if
- Severe visual problems
- Movement restriction due to orthopedic surgery in less than a year
- Treatment with botulinum toxin and/or baclofen pump in the last 6 months
- Contraindications to receive transcranial magnetic stimulation (epileptic history, metallic implants, neoplasm, etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Santiago Metropolitan, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Santiago Metropolitan, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.